RxDoctor Payments Data

Kimberly Borden

Nurse Practitioner · Amarillo, TXNPI 1225785058

Payments from drug & device makers

$3,716in general payments, 2019–2025

Across 168 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$803
  • AbbVie$467
  • Novo Nordisk$453
  • Lilly USA, LLC$362
  • Pfizer$315
  • Boehringer Ingelheim$284
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$52314%
  • Food & beverage$3,19486%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,716 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin48$36,725
FarxigaDapagliflozin Propanediol30$29,111
Synjardy XrEmpagliflozin/Metformin Hcl19$19,062
OzempicSemaglutide15$17,703
Tresiba Flextouch U-200Insulin Degludec19$16,532
QuliptaAtogepant11$11,423
SynthroidLevothyroxine Sodium45$4,533
Levothyroxine Sodium248$2,152
ProgesteroneProgesterone, Micronized43$1,591
Estradiol (Twice Weekly)Estradiol19$1,488
DottiEstradiol12$1,374
Montelukast Sodium54$841
Atorvastatin Calcium88$651
Omeprazole50$621
Metformin Hcl69$614

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr$284$55,78767 claims
AstraZenecaFarxiga$232$29,11130 claims
Novo NordiskOzempic$453$17,70315 claims
AbbVieQulipta, Synthroid$467$15,95656 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Amarillo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →